Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site

Fareed, 1999, Differentiation of low molecular weight heparins: applied and clinical considerations, 1

Fareed, 1998, Low molecular weight heparins: pharmacologic profile and product difference, Am J Cardiol, 82, 3L, 10.1016/S0002-9149(98)00105-2

Walenga, 1997, Biochemical and pharmacological rationale for the development of a synthetic pentasaccharide, Thromb Res, 86, 1, 10.1016/S0049-3848(97)00042-X

Carr, 1999, The heparin–protamine interaction, J Cardiovasc Surg, 40, 659

Shenoy, 1999, Development of heparin antagonists with focused biological activity, Curr Pharm Des, 5, 965, 10.2174/1381612805666230112205420

Langer, 1982, An enzymatic system for removing heparin in extracorporeal therapy, Science, 217, 261, 10.1126/science.7089564

Kilgore, 1999, Ex vivo reversal of heparinase after ischemia and reperfusion, J Pharmacol Exp Ther, 290, 1031

Michelsen, 1996, Heparinase I (neutralase) reversal of systemic anticoagulation, Anesthesia, 85, 339, 10.1097/00000542-199608000-00016

Jeske, 1999, In vitro studies on the biochemistry and pharmacology of low molecular weight heparins, Semin Thromb Hemostasis, 25, 27

Desai, 1993, Specificity studies on the heparin lyases from Flavobacterium heparinum, Biochemistry, 32, 8140, 10.1021/bi00083a012

Desai, 1993, Substrate specificity of the heparin lyases from Flavobacterium heparinum, Arch Biochem Biophys, 306, 461, 10.1006/abbi.1993.1538

Yamada, 1998, Structure of oligosaccharides isolated from heparan sulfate/heparin and substrate specificities of the degrading enzymes of bacterial origin, Trends Glycosci Glycotechnol, 10, 95, 10.4052/tigg.10.95

Ernst, 1989, Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I, Proc Natl Acad Sci U S A, 95, 4182, 10.1073/pnas.95.8.4182

Edens, 1992, Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low molecular weight heparin derivatives, J Pharmacol Sci, 81, 823, 10.1002/jps.2600810821

Kim, 1998, Determination of the structure of oligosaccharides prepared from acharan sulfate, Glycobiology, 8, 869, 10.1093/glycob/8.9.869

Walenga, 1985, Amidolytic antifactor Xa in the laboratory evaluation of heparin and low molecular weight fractions, Semin Thromb Hemostasis, 11, 100, 10.1055/s-2007-1004365

Iqbal, 1999, Heparinase is capable of neutralizing anticoagulant and anti-Xa effects of synthetic heparinominetic (pentasaccharide): potential clinical application, Blood, 94, 234a

Fareed, 2000, Heparinase is capable of neutralizing chemically synthesized heparin pentasaccharide and a natural high antithrombin III affinity, Ann Hematol, 79, A187a

Linhardt, 1990, Examination of the substrate specificity of heparin and heparan sulfate lyases, Biochemistry, 29, 2611, 10.1021/bi00462a026